261 related articles for article (PubMed ID: 16261883)
1. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
Cooperative Group for Reassessment of Defibrase
Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
[TBL] [Abstract][Full Text] [Related]
2. [Effect of plasma fibrinogen level-based defibrase therapy in patients with acute cerebral infarction].
Cai XB; Zhu ZS; Zhang MZ; Guo J; Wang HL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2124-7. PubMed ID: 19861283
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of defibrase in treatment of acute cerebral infarction.
Guo Y; Zuo YF; Wang QZ; Tang BS; Li FK; Sun Y
Chin Med J (Engl); 2006 Apr; 119(8):662-8. PubMed ID: 16635411
[TBL] [Abstract][Full Text] [Related]
4. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.
Sherman DG; Atkinson RP; Chippendale T; Levin KA; Ng K; Futrell N; Hsu CY; Levy DE
JAMA; 2000 May; 283(18):2395-403. PubMed ID: 10815082
[TBL] [Abstract][Full Text] [Related]
5. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
[TBL] [Abstract][Full Text] [Related]
6. Thrombolytic therapy with streptokinase in acute ischemic stroke.
; Hommel M; Cornu C; Boutitie F; Boissel JP
N Engl J Med; 1996 Jul; 335(3):145-50. PubMed ID: 8657211
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
[TBL] [Abstract][Full Text] [Related]
8. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W;
Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
[TBL] [Abstract][Full Text] [Related]
10. Effects of batroxobin with continuous transcranial Doppler monitoring in patients with acute cerebral stroke: a randomized controlled trial.
Yitao H; Kefu M; Bingshan T; Xuejun F; Ying Z; Zhili C; Xin J; Guo Y
Echocardiography; 2014 Nov; 31(10):1283-92. PubMed ID: 24684297
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of streptokinase for acute cerebral infarction.
Morris AD; Ritchie C; Grosset DG; Adams FG; Lees KR
QJM; 1995 Oct; 88(10):727-31. PubMed ID: 7493170
[TBL] [Abstract][Full Text] [Related]
12. Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions.
Camerlingo M; Salvi P; Belloni G; Gamba T; Cesana BM; Mamoli A
Stroke; 2005 Nov; 36(11):2415-20. PubMed ID: 16224085
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.
Lyden PD; Shuaib A; Lees KR; Davalos A; Davis SM; Diener HC; Grotta JC; Ashwood TJ; Hardemark HG; Svensson HH; Rodichok L; Wasiewski WW; Ahlberg G;
Stroke; 2007 Aug; 38(8):2262-9. PubMed ID: 17569876
[TBL] [Abstract][Full Text] [Related]
14. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
Diener HC; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Shuaib A; Ashwood T; Wasiewski W; Alderfer V; Hårdemark HG; Rodichok L;
Stroke; 2008 Jun; 39(6):1751-8. PubMed ID: 18369171
[TBL] [Abstract][Full Text] [Related]
15. Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial.
Shinohara Y; Nishimaru K; Sawada T; Terashi A; Handa S; Hirai S; Hayashi K; Tohgi H; Fukuuchi Y; Uchiyama S; Yamaguchi T; Kobayashi S; Kondo K; Otomo E; Gotoh F;
Stroke; 2008 Jun; 39(6):1827-33. PubMed ID: 18388340
[TBL] [Abstract][Full Text] [Related]
16. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
Yusuf S; Mehta SR; Xie C; Ahmed RJ; Xavier D; Pais P; Zhu J; Liu L;
JAMA; 2005 Jan; 293(4):427-35. PubMed ID: 15671427
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
[TBL] [Abstract][Full Text] [Related]
18. Defibrase, a purified fibrinolytic protease from snake venom in acute myocardial infarction.
Huang DX; Gai LY; Wang SR; Li TD; Yang TS; Zhi G; Du LS; Li LH
Acta Cardiol; 1992; 47(5):445-58. PubMed ID: 1441852
[TBL] [Abstract][Full Text] [Related]
19. Optimal intervention time and risk of the activating blood and removing stasis method in acute cerebral hemorrhage patients: A randomized placebo-controlled trial.
Ma Y; Zhang D; Lv Z; Cui Y; Fei Y; Chang T; Yu M; Lu J; Huang Q; Zhang Y; Xu P; Lan T; Wang J
Medicine (Baltimore); 2021 Jan; 100(2):e24214. PubMed ID: 33466200
[TBL] [Abstract][Full Text] [Related]
20. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
